A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: Potential use of Epstein-Barr virus polymerase chain reaction in multiple cancer types

Leukemia and Lymphoma

Volumn 56, Issue 5, 2015, Pages 1530-1532

  Tsai, Donald E ^a   Luskin, Marlise R ^a   Kremer, Brandon E ^a   Chung, Albert K ^a   Arnoldi, Sharon ^b   Paralkar, Vikram R ^a   Nasta, Sunita D ^a   Stadtmauer, Edward A ^a   Schuster, Stephen J ^a   Xavier, Marin ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Viracor IBT Laboratories   (United States)

^c SCRIPPS HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; IMMUNOGLOBULIN G;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER CELL; CUTANEOUS T CELL LYMPHOMA; DISEASE ACTIVITY; DISEASE MARKER; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FOLLICULAR LYMPHOMA; FOLLOW UP; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LETTER; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MARGINAL ZONE LYMPHOMA; MEASUREMENT; MULTIPLE CANCER; NASOPHARYNX CARCINOMA; NK T CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T CELL LYMPHOMA; VIREMIA; VIRUS DETECTION; VIRUS LOAD; GENETICS; NEOPLASMS; PILOT STUDY; VIROLOGY;

EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; NEOPLASMS; PILOT PROJECTS; POLYMERASE CHAIN REACTION;

EID: 84932105044     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.963577     Document Type: Letter

References (10)

1. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. NEngl J Med 1995;332:12-18.
2. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964;1:702-703.
3. Oyama T, Ichimura K, Suzuki R, et al. Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 2003;27:16-26.
4. Weiss LM, Movahed LA, Warnke RA, et al. Detection of Epstein-Barr viral genomes in Reed Sternberg cells of Hodgkin's disease. N Engl JMed 1989;320:502-506.
5. Lung ML, Chan KH, Lam WP, et al. In situ detection of Epstein-Barr virus markers in nasopharyngeal carcinoma patients. Oncology 1989;46:310-317.
6. Fan H, Kim SC, Chima CO, et al. Epstein-Barr viral load as a marker of lymphoma in AIDS patients. J Med Virol 2005;75:56-69.
7. Tsai DE, Douglas L, Andreadis C, et al. EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial. Am J Transplant 2008; 8: 1016-1024.
8. Kanakry JA, Li H, Gellert LL, et al. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial. Blood 2013;121:3547-3553.
9. Ahya VN, Douglas LP, Andreadis C, et al. Association between elevated whole blood EBER EBV PCR and reduced incidence of acute lung allograft rejection. J Heart Lung Transplant 2007; 26: 839-844.
10. Gandhi MK, Lambley E, Burrows J, et al. Plasma Epstein-Barr virus DNA is a biomarker for EBV-positive Hodgkin's lymphoma. Clin Cancer Res 2006; 12: 460-464.